AZN Related Guidance
-
AstraZeneca (AZN) Updates on Growth Strategies; Plans tor Headcount Reduction
-
AstraZeneca (AZN) to Relocate R&D Center; Sees $1.4B in One-Time Charges
-
AstraZeneca (AZN) Opens Lower After Reports Q4 Results
-
AstraZeneca (AZN) Tops Q3 EPS by 4c; Reaffirms FY12 Outlook
-
AstraZeneca (AZN) Suspends Buybacks; Aims to Maintain Financial Flexibility
-
Pfizer (PFE) Trims FY12 adj.-EPS Outlook on AstraZeneca (AZN) NEXIUM Deal
-
AstraZeneca (AZN) Announces Restructuring, Will Eliminate 7,300 Positions
-
Impax (IPXL) Unit Licenses Zomig Rights in U.S. from AstraZeneca (AZN); Updates FY12 Outlook
-
AstraZeneca (AZN) Reaffirms FY11 Outlook
-
AstraZeneca (AZN) to Cut 1,150 U.S. Sales, Leadership Jobs
-
AstraZeneca (AZN) Misses Q2 EPS by 7c; Raises FY11 EPS Outlook; Recommends Dividend; Potential Increase in Buybacks
-
AstraZeneca (AZN) Q4 Profits Climb, But Forecast Falls Short
-
AstraZeneca (AZN) Tops Q2 EPS by 24c; Guides Higher
-
AstraZeneca (AZN) Settles Infringement Suit with Teva (TEVA) Subsidiary; Confirms FY09 EPS Outlook
-
AstraZeneca (AZN) Sees FY08 Adj-EPS at Low End of $4.90-$5.05 Range
-
AstraZeneca (AZN) Tops Q3 Views; Raises Guidance
-
AstraZeneca (AZN) Tops Q2 EPS by 16c; Guides Up
-
Bristol-Myers Squibb (BMY) Reports Q2 Earnings, Raises FY07 EPS and Guides for FY08
-
AstraZeneca (AZN) Reports Q4 Results; Guides, Cutting 3K Jobs
-
AstraZeneca (AZN) Announces Distribution Agreement with Par Pharma (PRX); Updates FY Guidance
-
POZEN (POZN) Receives $40M Payment from AstraZeneca (AZN); Revised 2006 Guidance
-
AstraZeneca (AZN) Tops Q1 EPS Views; Guided Higher
-
PDII Announces Termination of AstraZeneca Fee-for-Service Contract
-
AZN Tops Q4 Views; Guides Above
Back to AZN Stock Lookup
